Home Halogens Urea, N-(2-chloroethyl)-N'-(4-methylcyclohexyl)-N-nitroso-

Urea, N-(2-chloroethyl)-N'-(4-methylcyclohexyl)-N-nitroso-

CAS No.:
13909-09-6
Catalog Number:
AG001A8N
Molecular Formula:
C10H18ClN3O2
Molecular Weight:
247.7218
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG001A8N
Chemical Name:
Urea, N-(2-chloroethyl)-N'-(4-methylcyclohexyl)-N-nitroso-
CAS Number:
13909-09-6
Molecular Formula:
C10H18ClN3O2
Molecular Weight:
247.7218
MDL Number:
MFCD00133811
IUPAC Name:
1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea
InChI:
InChI=1S/C10H18ClN3O2/c1-8-2-4-9(5-3-8)12-10(15)14(13-16)7-6-11/h8-9H,2-7H2,1H3,(H,12,15)
InChI Key:
FVLVBPDQNARYJU-UHFFFAOYSA-N
SMILES:
ClCCN(C(=O)NC1CCC(CC1)C)N=O
UN Number:
3249
Properties
Complexity:
242  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
247.109g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
247.723g/mol
Monoisotopic Mass:
247.109g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
61.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.3  
Literature
Title Journal
[Comparison of two regimens of postoperative concurrent chemoradiotherapy in adult patients with grade III-IV cerebral gliomas]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120201
Quantification of meCCNU-induced dG-dC crosslinks in oligonucleotide duplexes by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid communications in mass spectrometry : RCM 20110730
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. Journal of medicinal chemistry 20110714
ANCA vasculitis: time for a change in treatment paradigm? Not yet. Rheumatology (Oxford, England) 20110601
[Secondary membranous nephropathy: The topics of membranous lupus nephritis]. Nihon Jinzo Gakkai shi 20110101
Nitrosourea chemotherapeutic agents: 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. Report on carcinogens : carcinogen profiles 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
[Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101101
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20091201
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. Acta pharmacologica Sinica 20091001
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry 20081113
Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Oral oncology 20080101
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas. Therapeutics and clinical risk management 20071001
Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients. Pediatric transplantation 20070801
[Clinical significance of mustoforan in management of malignant glioma]. Voprosy onkologii 20070101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
[Comparison of the long term results between two conditioning regimens MCC and BuCy in chronic myelocytic leukemia after allogeneic stem cell transplantation]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20060301
Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome. Acta oncologica (Stockholm, Sweden) 20060101
Adjuvant therapy for colon cancer: a historical perspective. Journal of the National Cancer Institute 20040804
Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Journal of the National Cancer Institute 20040804
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. Report on carcinogens : carcinogen profiles 20040101
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (MeCCNU). Report on carcinogens : carcinogen profiles 20020101
National Surgical Adjuvant Breast and Bowel Project trials in colon cancer. Seminars in oncology 20010201
Anticancer drug-induced kidney disorders. Drug safety 20010101
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clinical cancer research : an official journal of the American Association for Cancer Research 20000501
Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. American journal of kidney diseases : the official journal of the National Kidney Foundation 19861101
Comparative nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) and chlorozotocin: functional-structural correlations in the Fischer 344 rat. Toxicology and applied pharmacology 19860315
Chemical cholecystitis after intrahepatic chemotherapy. The case for prophylactic cholecystectomy during pump placement. Diseases of the colon and rectum 19860301
Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep). An Eastern Cooperative Oncology Group study. American journal of clinical oncology 19851001
Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships. International journal of radiation oncology, biology, physics 19820101
Nephrotoxicity of nitrosoureas. Cancer 19810915
Chemotherapeutic effects of some alkylating derivatives of nitrosourea on the development of tumors transplacentally induced in rats by ENU. Acta neuropathologica 19760131
A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer. Cancer research 19740101
Properties